Patents by Inventor Michel Manfait

Michel Manfait has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130077837
    Abstract: This invention relates to a method for identifying and classifying carcinomas on the skin of a subject by a FTIR or Raman spectrometer coupled with a micro-imaging system.
    Type: Application
    Filed: March 25, 2011
    Publication date: March 28, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT SNC
    Inventors: Cyril Gobinet, Pierre Jeannesson, Michel Manfait, Olivier Piot, David Sebiskveradze, Valeriu Vrabie
  • Publication number: 20040253575
    Abstract: A method for identification of a functional biological characteristic of a living material including a) subjecting at least one reference biological material for a functional biological to physical analysis Apr to establish a spectrum SAPr, b) calculating discriminant factors CPnr by a statistical analysis of all or part of the spectrum SAP, c) determining a specific functional descriptor Dfs of the functional biological characteristic from the discriminant factors Cpnr, d) subjecting the living material to be analyzed to steps (a) and (b), and e) comparing the discriminating factors CP of the living material to be analyzed with the specific functional descriptor Dfs to deduce a possible functional biological characteristic of the living material to be analyzed.
    Type: Application
    Filed: December 27, 2002
    Publication date: December 16, 2004
    Applicant: Bioalliance Pharma (S.A.)
    Inventors: Michel Manfait, Dhruvananda Sockalingum
  • Patent number: 5580750
    Abstract: A method is described to determine multidrug resistance in living cells by laser scanning confocal fluorescence microscopy of doxorubicin in sensitive and resistant tumor cells. The intracellular distribution of doxorubicin in K562 cells has been studied by laser scanning confocal fluorescence microscopy. A different fluorescence pattern has been observed in sensitive and resistant cells. An intense fluorescence signal is evident on the plasma membrane of K562R cells with multidrug resistance. The fluorescence imaging of the drug offers then a new method--non destructive--to discriminate between sensitive and resistant cells, with high potential in the diagnosis of resistance in tumors in vivo. The differences in the intracellular drug distribution, as seen by laser scanning confocal fluorescence microscopy, moreover offer new indications on the mode of action of the drug in the living cell.
    Type: Grant
    Filed: April 6, 1993
    Date of Patent: December 3, 1996
    Inventors: Silvia M. Doglia, Anna M. Villa, Michel Manfait